Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe. The aim of this observational study is to collect data
from children with Prader-Willi Syndrome, who have been treated off-label with Norditropin®
for more than 12 months to seek approval for Norditropin® treatment with Prader-Willi
Syndrome.